Tradestie Institutional Equity Comparison Engine

EMR vs ABBNY โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

EMR Overall Edge

EMR Captures Institutional Edge (4โ€“0 Pillars ยท 9โ€“1 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Emerson Electric Co. (EMR) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, EMR trades at 22.9x Forward P/E with 24.8% operating margin (+7.1% YoY revenue) versus ABBNY at N/M Forward P/E and N/A operating margin (N/A YoY). In options structure, EMR sits in CONSOLIDATION (6th %ile IV; Dealer Gamma Walls on Pro) against ABBNY sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner EMR
EMR 22.9x vs ABBNY N/M Fwd P/E
Growth & Margin Winner EMR
Op Margin 24.8% vs N/A ยท YoY +7.1% vs N/A
Momentum & Technical Winner EMR
1Y +25.4% vs +16.4% ยท 52W Pos 78% vs 38%
Options & Structure Winner EMR
CONSOLIDATION (6th %ile IV) vs UNCLASSIFIED (N/A IV)
EMR NYSE
Emerson Electric Co.
Electronic & Other Electrical Equipment (No Computer Equip)
$161.06
-3.2% 1D
Market Cap $91.6B
1M Return -0.25%
1Y Return +25.38%
Forward P/E 22.9x
Unified AI Score
51.2 / 100 HOLD
Tech 40.0 Fund 48.0 Flow 59.0 Mom 45.9
ABBNY US Equity
ABBNY
Institutional Equity
$83.75
+0.01% 1D
Market Cap N/A
1M Return -9.64%
1Y Return +16.43%
Forward P/E N/M
Unified AI Score
55.7 / 100 HOLD
Tech 83.0 Fund 56.0 Flow 50.0 Mom 50.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: EMR +25.38% ABBNY +16.43% Spread: +10.69 pp (EMR Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
EMR TTM Op. Margin: 24.8% ABBNY TTM Op. Margin: N/A
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on EMR vs ABBNY. Trailing 12-month operating profitability (EMR 24.8% vs ABBNY N/A) and valuation multiples (EMR 22.9x vs ABBNY N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: EMR (9) vs ABBNY (1)
Institutional Metric EMR ABBNY Criterion Row Winner
Market Capitalization Scale $91.6B N/A Larger Scale EMR
Trailing P/E Ratio Valuation 34.9x N/M Lower Multiple EMR
Forward P/E Ratio Valuation 22.9x N/M Lower Multiple EMR
Revenue Growth (YoY) Growth +7.1% N/A Higher Growth EMR
Operating Margin (TTM) Profitability 24.8% N/A Higher Margin EMR
Net Profit Margin Profitability 14.2% N/A Higher Margin EMR
Return on Equity (ROE) Capital Efficiency 13.1% N/A Higher ROE EMR
52-Week Range Position Momentum 78% ($123โ€“$172) 38% ($67โ€“$110) Stronger Trend EMR
Beta / 30D Volatility Risk Regime 1.45ฮฒ ยท 34% Vol 1.81ฮฒ ยท 41% Vol Lower Realized Risk EMR
Unified Institutional Score Composite Signal 51.2 / 100 (HOLD) 55.7 / 100 (HOLD) Higher Composite ABBNY

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full EMR vs ABBNY Buy Guide
EMR CONSOLIDATION
68d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 6th %ile
IV Regime Compressed (<25th %ile)
Live EMR Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
ABBNY UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live ABBNY Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither EMR nor ABBNY registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.